Amber Wells

Amber Wells is a seasoned professional in clinical science with extensive experience across prominent pharmaceutical organizations. Currently serving as Senior Director of Clinical Science at FogPharma since May 2024, Amber previously held leadership roles such as Director of Clinical Science and Sr. Clinical Scientist at Bristol Myers Squibb from April 2020 to May 2024. Prior to that, Amber was a Clinical Research Scientist at Celgene and managed clinical research at Amgen. With a background that includes positions at Arvinas, Inc., Pfizer, OSI Pharmaceuticals, and academic experience as an Assistant Professor at Albert Einstein College of Medicine, Amber has a strong foundation in translational and clinical science, bolstered by a PhD in Cell and Molecular Biology from the University of Pennsylvania and a BS in Physiological Science from UCLA.